Aflibercept-ED

N/A

Report date: 2025/08/01 14:25:41

Base Information

Drug NameAflibercept-ED
Drug Alias Name阿柏西普/原花青素WBP-101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionPlacental Growth Factor inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor APlacental Growth Factor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWincal Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesWincal Biopharm Inc
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A